Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXI
1826
Twenty One Capital Inc
XXI
$3.66B
| $90.5K | ﹤0.01% |
+10,334
| New | +$108K |
|
1827
Coursera
COUR
$1.64B
| $89.4K | ﹤0.01% |
12,153
-58,481
| -83% | -$509K |
|
1828
ImmunityBio
IBRX
$8.68B
| $88.7K | ﹤0.01% |
44,780
-4,678
| -9% | -$10.6K |
|
|
PAII.WS
1829
Pyrophyte Acquisition Corp II Warrants
PAII.WS
| $86.6K | ﹤0.01% |
216,601
+16,601
| +8% | +$6.63K |
|
1830
Clear Channel Outdoor Holdings
CCO
$1.21B
| $85.9K | ﹤0.01% |
+38,854
| New | +$72.1K |
|
1831
Weave Communications
WEAV
$583M
| $84K | ﹤0.01% |
+11,065
| New | +$73.5K |
|
1832
Rekor Systems
REKR
$80.3M
| $83.8K | ﹤0.01% |
+60,751
| New | +$124K |
|
1833
American Resources Corp
AREC
$291M
| $83.3K | ﹤0.01% |
+33,597
| New | +$112K |
|
|
GTENW
1834
Gores Holdings X Warrants
GTENW
$6.27M
| $82.9K | ﹤0.01% |
97,503
-49,297
| -34% | -$45.3K |
|
1835
Adecoagro
AGRO
$1.59B
| $82.1K | ﹤0.01% |
10,354
-71,498
| -87% | -$561K |
|
1836
Exagen
XGN
$184M
| $81.6K | ﹤0.01% |
+13,421
| New | +$122K |
|
1837
Radiant Logistics
RLGT
$403M
| $81.5K | ﹤0.01% |
+12,878
| New | +$79.9K |
|
|
OGG
1838
Osisko Gold Group
OGG
$976M
| $81.4K | ﹤0.01% |
+23,334
| New | +$80.2K |
|
1839
GSI Technology
GSIT
$229M
| $81.4K | ﹤0.01% |
+13,102
| New | +$93.5K |
|
|
NFGC
1840
New Found Gold
NFGC
$784M
| $80.6K | ﹤0.01% |
+27,148
| New | +$66.6K |
|
1841
Kenvue
KVUE
$37.1B
| $80.5K | ﹤0.01% |
4,664
-19,856
| -81% | -$325K |
|
|
LAC
1842
Lithium Americas
LAC
$1.18B
| $80.2K | ﹤0.01% |
+18,400
| New | +$106K |
|
|
LOKVW
1843
DELISTED
Live Oak Acquisition Corp V Warrants
LOKVW
| $78.8K | ﹤0.01% |
79,950
-190,914
| -70% | -$158K |
|
1844
Virgin Galactic
SPCE
$450M
| $78.3K | ﹤0.01% |
+24,407
| New | +$91.9K |
|
1845
Vestis
VSTS
$1.7B
| $78.3K | ﹤0.01% |
11,742
-43,064
| -79% | -$251K |
|
|
EGHAR
1846
EGH Acquisition Corp Rights
EGHAR
| $77.7K | ﹤0.01% |
310,688
-60,714
| -16% | -$16.1K |
|
|
TALK
1847
DELISTED
Talkspace
TALK
| $77K | ﹤0.01% |
+21,217
| New | +$67.3K |
|
|
BEAGR
1848
Bold Eagle Acquisition Corp Right
BEAGR
| $76.8K | ﹤0.01% |
240,000
-286,262
| -54% | -$101K |
|
1849
Blend Labs
BLND
$350M
| $76.4K | ﹤0.01% |
+25,123
| New | +$80.1K |
|
1850
Digital Turbine
APPS
$1.31B
| $74.8K | ﹤0.01% |
+14,956
| New | +$84.6K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.